• Home
• About Us
  • Manufacturing Capabilities
  • Regulatory Approvals
  • Our People
  • Research & Development
  • Corporate Citizenship
  • Global Footprint
  • Contract Manufacturing Opportunities
• Our Products
  • Our Product Range
    • Allergic Disorders
    • Analgesics & Antipyretic
    • Anti-infectives
    • Anti-Inflammatory & Analgesic
    • Cardiovascular
    • Central Nervous System
    • Cough & Cold
    • Endocrine & Diabetes
    • Eye Care
    • GastroIntestinal
    • Intravenous Fluids
    • Muscloskeletal
    • Oncology
    • Other products
    • Respiratory
    • Skin Care
    • Vitamins & Minerals Supplement
• Health Point
  • Health Problem
  • Find your Doctors/ Physicians
  • Ambulance Services
  • Hospital/ Clinics
  • 24 Hours Pharmacy
  • Normal Range of Diagnostic Tests
• Investor Relations
  • Key Company Information
  • Board Details
  • Corporate Governance
  • Company Documents
  • Share Information
    • Rights of shareholders
    • Transfer Restrictions
  • Financial Reports
  • News & Announcements
  • Advisers
• Latest News
• Beximco for Doctors
• Contact Us

Investor Relations

This section of our website contains essential information on Beximco Pharmaceuticals Ltd. You can view and download our financial reports and keep up to-date with the latest news and company information.

The information on this section is being disclosed for the purposes of AIM Rule 26.  Information was last updated on 16th August 2007.


For latest share prices [LSE: BXP, DSE: BEXPHARMA] click on the following links:

AIM (London Stock Exchange)

Dhaka Stock Exchange

Chittagong Stock Exchange